MongoDB Soars on AI Tailwinds, Nvidia Faces “Show Me” Moment as Hype Meets Earnings

The AI trade’s intensity hit a fork in the road today. MongoDB rode a surprise earnings beat to double digit gains, but Wall Street’s gaze is now fixed squarely on Nvidia’s report card. It’s a bifurcation moment, some AI bets are paying off, others need to start proving they’re more than just hype.

📈 AI Market Movers & Trends

MongoDB (MDB) just made Wall Street believers again, its stock spiked 13% after crushing earnings, with CEO Dev Ittycheria attributing the upside to “accelerating enterprise adoption of AI powered apps.” Translation, MongoDB is no longer just a database company, it’s selling the picks and shovels for AI's software gold rush.

But not every AI stock is flying high. Nvidia (NVDA) sits at the center of the storm, with Q2 earnings expected to confirm whether the hyperscaler chip bonanza is still roaring or beginning to plateau. Street expectations are sky high, Goldman projects hyperscalers will have dropped over $40 billion on AI infrastructure by year end. The question now, will Nvidia's actual data center revenue rise fast enough to justify its market gobbling valuation?

Investors are clearly getting smarter, and pickier. Snowflake (SNOW) and UiPath (PATH), once AI narrative darlings, are under scrutiny. The broad market is asking for proof, where are the profits, and is all this AI spend generating actual ROI?

Meanwhile, some contrarian voices are calling the top. Analysts like those at The Guardian warn the AI boom's sugar high may be wearing off, even if it takes time to show up in earnings. “We're entering the ‘show me’ phase,” said one analyst at BofA. “Narratives are old. Numbers are king.”

Bottom line, AI winners are separating from the pack. MongoDB shows what upside looks like when the story and fundamentals finally converge.

💸 Funding Watch

Quietly, pharma is becoming one of AI’s most potent proving grounds, and investors are paying attention. This week, a stealth mode biotech AI startup out of the Bay Area closed a $120 million Series B led by Andreessen Horowitz, with participation from SoftBank Vision Fund 2. The company, still operating under NDAs with major pharma partners, is reportedly using large multimodal AI models to de risk Phase II trials, what one VC described as “GPT 4 meets CRISPR.”

While the deal draws attention, it's the signal behind it that matters, AI bio convergence is the next bull narrative, and serious capital is now flowing in to back it. With Big Pharma shedding underperforming blockbuster programs, see recent cuts from Novartis and AstraZeneca, there's growing purchase for AI native startups capable of rebooting drug discovery timelines.

On the enterprise software side, the AI assistant wars among Big Tech have trickled down to startups. Voiceflow, the design and deploy platform for AI conversational systems, just raised a $55 million Series C led by Index Ventures. The implicit bet? As LLMs continue to level the language game, UX and orchestration layers are where value creation lives.

Meanwhile, international capital is heating up. Chinese investors, fresh off the 2025 National Science Foundation rankings release, are increasingly backing academia spinout AI labs aiming for foundational model plays, with at least three $30M+ seed rounds announced in the past month.

Watch this space. The AI VC wave isn’t ebbing, it’s just getting smarter, sharper, and more specific.

🪙 Crypto Moves

The crypto AI marriage is getting more volatile, and more real. ChainGPT, long dismissed as another AI on chain gimmick, surged 28% this week after revealing a partnership with Binance Labs to roll out a secure, compliant AI agent for DeFi portfolio management. The sentiment shift was fast and loud, DEX volume on its token jumped 4x overnight.

But behind the trading spike is something deeper. A handful of tokens, including Numeraire (NMR) and Ocean Protocol (OCEAN), are starting to anchor real services, prediction markets, data management, and inference marketplaces, that could become the rails for decentralized AI tooling.

Still, for every signal, there’s noise. Lightchain AI, a buzzy token hyped in Telegram groups, was flagged in DFPI’s updated crypto scam tracker this week. Reddit blew up after a user traced its GitHub to what appears to be a recycled LLM wrapper with fake devs. Consider that your PSA, If the code doesn’t check out, the pump won’t last.

Kraken’s new category index for AI tokens also didn’t go unnoticed. The exchange’s decision to separate out AI & Big Data tokens from Web3 gaming and DeFi plays is a bid to front run a structural narrative shift in how these ecosystems will eventually converge.

For crypto traders and builders, the takeaway is surgical, being first to real utility, not hype, is where lasting value will accrue. Don’t chase AI. Build or bet on where it’s actually being delivered.

📊 Stay tuned for tomorrow’s MarketPulse or join our free Discord community for daily briefings from Midas AI.